Výsledky vyhledávání - Christopher G. Azzoli

Upřesnit hledání
  1. 1
    Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer

    Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer Autor Anna F. Farago, Christopher G. Azzoli

    Vydáno 2017
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

    American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer Autor Christopher G. Azzoli, Giuseppe Giaccone, Sarah Temin

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

    2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer Autor Christopher G. Azzoli, Sarah Temin, Giuseppe Giaccone

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Basic Mechanisms of Therapeutic Resistance to Radiation and Chemotherapy in Lung Cancer

    Basic Mechanisms of Therapeutic Resistance to Radiation and Chemotherapy in Lung Cancer Autor Henning Willers, Christopher G. Azzoli, Wil L. Santivasi, Fen Xia

    Vydáno 2013
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

    Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors Autor Marie Brevet, Melissa L. Johnson, Christopher G. Azzoli, Marc Ladanyi

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

    Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer Autor Jamie E. Chaft, Andreas Rimner, Walter Weder, Christopher G. Azzoli, Mark G. Kris, Tina Cascone

    Vydáno 2021
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung

    Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung Autor Jamie E. Chaft, Camelia S. Sima, Michelle S. Ginsberg, James Huang, Mark G. Kris, William D. Travis, Christopher G. Azzoli

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping

    Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping Autor Geoffrey R. Oxnard, Vincent A. Miller, Mark E. Robson, Christopher G. Azzoli, William Pao, Marc Ladanyi, Maria E. Arcila

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer

    BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamou... Autor John D. Hainsworth, Fang Ting Liang, Jane E. Huang, David A. Karlin, Kenneth Russell, Leonardo Faoro, Christopher G. Azzoli

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.

    Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Autor Douglas W. Ball, Christopher G. Azzoli, S B Baylin, David Chi, Shijuan Dou, H. Donis-keller, Arunthathi Cumaraswamy, Michael Borges, B D Nelkin

    Vydáno 1993
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers

    A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers Autor Bob T. Li, Alexander Drilon, Melissa L. Johnson, Meier Hsu, Camelia S. Sima, C. McGinn, Hirofumi Sugita, Mark G. Kris, Christopher G. Azzoli

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    The Prognostic Impact of KRAS, Its Codon and Amino Acid Specific Mutations, on Survival in Resected Stage I Lung Adenocarcinoma

    The Prognostic Impact of KRAS, Its Codon and Amino Acid Specific Mutations, on Survival in Resected Stage I Lung Adenocarcinoma Autor Benjamin Izar, Haiyu Zhou, Rebecca S. Heist, Christopher G. Azzoli, Alona Muzikansky, Emily Scribner, Lindsay A. Bernardo, Dora Dias‐Santagata, A. John Iafrate, Michael Lanuti

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib

    Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib Autor Melissa L. Johnson, Greg J. Riely, Naiyer A. Rizvi, Christopher G. Azzoli, Mark G. Kris, Camelia S. Sima, Michelle S. Ginsberg, William Pao, Vincent A. Miller

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer

    Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer Autor Kevin C. De Braganca, Yelena Y. Janjigian, Christopher G. Azzoli, Mark G. Kris, M. Catherine Pietanza, Craig Nolan, Antonio Omuro, Andrei I. Holodny, Andrew B. Lassman

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy

    Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy Autor Karen Kelly, Christopher G. Azzoli, Petr Zatloukal, István Albert, Peter Jiang, David Bodkin, José Rodrigues Pereira, Erzsébet Juhász, Nicholas Iannotti, Garry Weems, Tony Koutsoukos, Jyoti D. Patel

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Impact on Disease-Free Survival of Adjuvant Erlotinib or Gefitinib in Patients with Resected Lung Adenocarcinomas that Harbor EGFR Mutations

    Impact on Disease-Free Survival of Adjuvant Erlotinib or Gefitinib in Patients with Resected Lung Adenocarcinomas that Harbor EGFR Mutations Autor Yelena Y. Janjigian, Bernard J. Park, Maureen F. Zakowski, Marc Ladanyi, William Pao, Sandra P. D’Angelo, Mark G. Kris, Ronglai Shen, Junting Zheng, Christopher G. Azzoli

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancer

    A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancer Autor Daniel T. Milton, Christopher G. Azzoli, Robert T. Heelan, Ennapadam Venkatraman, Jorge Gómez, Mark G. Kris, Lee M. Krug, William Pao, Naiyer A. Rizvi, Megan Dunne, Vincent A. Miller

    Vydáno 2006
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions

    Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions Autor Zofia Piotrowska, Daniel B. Costa, Geoffrey R. Oxnard, Mark S. Huberman, Justin F. Gainor, Inga T. Lennes, Alona Muzikansky, Alice T. Shaw, Christopher G. Azzoli, Rebecca S. Heist, Lecia V. Sequist

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer

    Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall‐cell lung cancer Autor Daniel T. Milton, Gregory J. Riely, Christopher G. Azzoli, Jorge Gómez, Robert T. Heelan, Mark G. Kris, Lee M. Krug, William Pao, Barbara Pizzo, Naiyer A. Rizvi, Vincent A. Miller

    Vydáno 2007
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non–Small-Cell Lung Cancer

    Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non–Small-Cell Lung Cancer Autor Naiyer A. Rizvi, Gregory J. Riely, Christopher G. Azzoli, Vincent A. Miller, Kenneth Ng, John J. Fiore, Gloria Chia, Martin Brower, Robert T. Heelan, Michael Hawkins, Mark G. Kris

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: